FLDM - フリュ―ダイム （Fluidigm Corporation）

Fluidigm Corporation (NASDAQ:FLDM) shares, rose in value on Friday, 11/05/21, with the stock price down by -2.98% to the previous days close as strong demand from buyers drove the stock to $4.88. Actively observing the price movement in the last trading, the stock closed the session at $5.03, falling within a range of $4.7617 and Fluidigm Corporation (NASDAQ: FLDM) Stock Price Forecast: $100 Read More »

Fluidigm (NASDAQ:FLDM) and Singular Genomics Systems (NASDAQ:OMIC) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, profitability and risk. Earnings and Valuation This table compares Fluidigm and Singular Genomics Systems top-line revenue, earnings per []

Fluidigm (NASDAQ:FLDM) is scheduled to be releasing its earnings data after the market closes on Monday, November 8th. Fluidigm has set its FY 2021 guidance at EPS and its Q3 2021 guidance at EPS.Persons interested in registering for the companys earnings conference call can do so using this link. Fluidigm (NASDAQ:FLDM) last issued its quarterly []

Fluidigm Corporation (NASDAQ:FLDM) price on Friday, October 29, rose 1.98% above its previous days close as an upside momentum from buyers pushed the stocks value to $5.15. A look at the stocks price movement, the close in the last trading session was $5.05, moving within a range at $5.05 and $5.18. The beta value (5-Year Fluidigm Corporation (NASDAQ: FLDM) Could Slash -133.01% Soon Read More »

SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report third quarter 2021 financial results on Monday, November 8, 2021, after the close of the market.

Department of Womens and Childrens Health to Work with Fluidigm on CyTOF Research Applications, Product Development Department of Womens and Childrens Health to Work with Fluidigm on CyTOF Research Applications, Product Development

The Global Genomics Market Research Report 2021-2030 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand, and supply data (as applicable). The research analysts

Biochips are increasingly being used in the field of biomedical and biotechnological research. With the advancement of technology, there has been a rise in the adoption of biochips in proteomics, such as in microarrays. The advantages of protein biochips include

The Tumor Genomics Market is expected to reach a market size of USD 56.54 Billion, to register a CAGR of +12% by 2028. Tumor genomic assays (or tests) analyze a sample of a cancer tumor to see how active certain

Get Free Sample PDF (including full TOC, Tables and Figures) of Medical Microfluidic Devices Market: https://www.reportsnreports.com/contacts/requestsample.aspx?name=4424155 #Key Players- Roche Abbott Fluidigm Corporation Johnson & Johnson Siemens Healthcare Agilent Bio-Rad Laboratories Market segment by Type: Polymer Glass Silicon Other Market segment by Application: []

Global Polymerase Chain Reaction (PCR) Technologies Market highlights the information about the dominant players industries and market, technologies, and abilities over the trends and the developments of the industries. After deep research and analysis by the experts, they also disclosed the data about the strong contenders contributing in the market growth and expansion and challenging []

Radio Frequency Front-End Module Market is Projected to Showcase Significant Growth Up to 2027, SWOT Analysis, Covid-19 Analysis, Business Growth and Segmental Analysis Latest research on Global Radio Frequency Front-End Module Market report covers forecast and analysis on a worldwide, regional

LP INFORMATION recently released a research report on the Microfluidic Chips analysis, which studies the Microfluidic Chips industry coverage, current market competitive status, and market outlook and forecast by 2026. Global Microfluidic Chips Market 2021-2026 Research Report categorizes the global Microfluidic Chips by key players, product type, applications and regions,etc. The report also covers the latest industry data, key []

SOUTH SAN FRANCISCO, Calif., July 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report second quarter 2021 financial results on Thursday, August 5, 2021, after the close of the market.